Litigation Challenges Prioritization of Race or Ethnicity in Allocating COVID-19 Therapies
Within a few weeks after the New York guidelines were issued, the federal lawsuits commenced.
covid-19 therapeutic antibodies
-
Read more: Litigation Challenges Prioritization of Race or Ethnicity in Allocating COVID-19 Therapies -
Read more: How to Fairly Allocate Scarce COVID-19 Therapies How to Fairly Allocate Scarce COVID-19 Therapies
The same ethical goals identified for vaccine allocation are also relevant for COVID-19 therapy allocation.
-
Read more: How Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing? How Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing?
The difficult manufacturing issues involved in the therapeutic antibody context, and what might be done to address them.
-
Read more: Why Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19? Why Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19?
The rapid development of therapeutic antibodies is a triumph of biomedical innovation. But they won’t help unless they make it to patients.
